Tools
ToolsFariyike, Opeoluwa, Johnson, Nicholas A., Craig, Paul, Nobes, Jenny, Levell, Nick J. and Venables, Zoe (2025) Understanding acral Lentiginous Melanoma: From clinic to guidelines. Clinical and Experimental Dermatology, 51 (6). pp. 967-976. ISSN 0307-6938
Preview |
PDF (Fariyike_etal_2025_llaf501_AAM)
- Accepted Version
Available under License Creative Commons Attribution. Download (787kB) | Preview |
Abstract
Invasive acral lentiginous melanoma (ALM) is a distinct melanoma subtype that primarily affects non-sun-exposed extremities, such as the palms, soles and nail beds. It is characterized by lentiginous proliferation of atypical melanocytes along the basal layer of glabrous skin. While ‘acral melanoma’ is a broad term referring to melanomas arising on acral sites, ‘acral lentiginous melanoma’ specifically refers to this lentiginous subtype. ALM is disproportionately represented among individuals with darker skin phototypes, including Black, Hispanic and Asian populations, in whom it accounts for a higher proportion of melanoma cases than in White populations. While it comprises just 2–3% of all melanomas, ALM has a poorer prognosis, with 5-year melanoma-specific survival rates averaging 80.6%. The pathogenesis of ALM remains incompletely understood. It is not primarily induced by ultraviolet (UV) radiation but is often associated with mechanical stress on weight-bearing or high-friction areas. Recurrent mutations in KIT, NF1, TERT and TP53 are also frequently observed, particularly in older and Asian patients, underscoring ALM’s distinct molecular profile. Diagnosis is often delayed due to its subtle presentation as irregularly pigmented macules or patches. Histologically, ALM demonstrates lentiginous basal proliferation with dermal invasion. Management typically involves wide local excision, although advanced disease may require lymph node surgery, radiotherapy or systemic treatment. Prognosis is influenced by tumour thickness, ulceration and sentinel lymph node involvement. Persistent disparities in outcomes highlight the need for greater awareness, earlier diagnosis and targeted management strategies to address the biological and sociodemographic complexities of ALM.
| Item Type: | Article |
|---|---|
| Additional Information: | Publisher Copyright: © The Author(s) 2025. Published by Oxford University Press on behalf of British Association of Dermatologists. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Centres > Public Health Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 14 Nov 2025 17:30 |
| Last Modified: | 05 Jun 2026 08:18 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/101009 |
| DOI: | 10.1093/ced/llaf501 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |